Caladrius Biosciences, Inc. (Caladrius, formerly NeoStem) is among the first of a new breed of immunotherapy companies with proven expertise and unique experience in cell process optimization, development, and manufacturing. Caladrius is a cell therapy leader with late-stage clinical programs based on a proprietary platform technology for immuno-oncology, as well as additional platform technologies for ischemic repair and immunomodulation, and capabilities that support other cell therapy developers. This integrated approach supports the industry in bringing significant life-improving medical treatments to market.
Allendale, US
221 (est)+22%

Key People at Caladrius

Robin L. Smith

Robin L. Smith


Caladrius Locations

Allendale, US
Mountain View, US

Caladrius Metrics

Caladrius Summary

Founding Date


Market capitalization

$28.9 M

Closing share price


Caladrius Market Value History

Caladrius Company Life